Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.55%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.98%2016-09-13
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,8930.19%2016-07-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-09-06
Mr. James J. VaughnChief Commercial Officer29,079less than 0.1%2016-08-08
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.158.91327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.646.635,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.27.27327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227028.14
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.351.2135,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.221.6729,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.16.56327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.29.6835,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8513.39327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.19.7735,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.924.3632,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61385.8734,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.017.4315,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28564.3631,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.314.9326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.084.3624,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-9.096,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-7.7927,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-13.1124,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-0.1427,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-0.3812,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-0.3824,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1212.2630,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9815.2730,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.126.1430,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9611.3630,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.166.129,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-6.59Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-4.0129,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-8.43Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-8.2329,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-2.14Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-6.8521,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-8.496,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-12.67Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-11.43Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-10.1521,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-16.08Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-17.3422,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-19.376,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-5.07Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.081.5622,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-2.01Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-2.8922,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.26.8312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2112.08Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.779.89Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.228.0222,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271898.22312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.119.32312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.311.95Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.485.7924,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.787.0722,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6210.1Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3616.4623,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7511.31311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27818.2222,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.523.03311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.285.2622,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.584.8115,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.666.72311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27818.2224,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-7.27308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-2.6Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.513.7318,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-1.18308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-4.76Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-12.1221,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-16.326,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-15.5Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-12.4121,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-6.8818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-1.52308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-2.6Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-2.4418,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-13.37313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-14.84Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-10.1818,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-11.1921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-7.216,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-11.4318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-11.53Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-11.8621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-11.8621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-13.1919,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-17.29318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-15.57Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-13.5817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-13.5817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-12.3313,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-12.83323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-18.11Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-18.5617,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-19.19
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-19.8813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-20.4
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-19.736,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-20.79
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-20.88
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-22.047,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-21.43327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-19.84
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-18.456,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-14.91
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-15.117,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-15.79Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-18.8817,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-18.8112,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-2.6Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.485.1512,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.432.2812,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.585.18
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.43.877,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.962.6
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.52.892,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.533.8
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.084.2514,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.541.566,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.54.3617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.74.8114,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.75.34333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.955.15Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28844.3617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.684.966,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.128.91288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.268.6636,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.78.46338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.526.95288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.27.27Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.15.07288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28844.3617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.552.114,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-11.67Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-17.11343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-13.5217,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-13.511,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-16.0314,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-13.45348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-7.79Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-16.5414,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-16.992,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-16.49353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-15.84Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-4.1714,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-18.616,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-14.66358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-15.94Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-17.43Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-18.7214,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-12.12363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-12.41Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-12.41Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-12.88Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-13.9813,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-13.55367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-9.42
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-11.5326,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-13.75
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-14.64Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-13.2717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-2.47
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-3.31Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.181.2113,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.692.71
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.423.586,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.654.62372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.955.15Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.984.4318,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.82.2Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-3.513,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-2.86377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-2.83Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-2.83Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-2.86377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-5.9819,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-5.89Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-2.413,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-2.96
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-2.96
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-2.96
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-1.98
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-1.98
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-1.98
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.190.55
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.60.55
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.710.55
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52852.53Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.384.13
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.84.13
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.14.13
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.73.84382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-0.41
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-0.51
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-0.51
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.711.620,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.761.620,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2410.85
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0910.85
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1310.85
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.611.61Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.611.61Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1810.3914,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.026.226,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.110.6Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.19.77Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.79.27382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28284.3617,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.856.17,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.26.41Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1512.26387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.87.07Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.482.27,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.633.91
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.725.64
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.163.91
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3112.77
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1612.64
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7812.77
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3512.08392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.985.45
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.665.45
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.536.84
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.197.31
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.487.31
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.87.27Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.529.07
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.59.857,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7412.64
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4912.64
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9419.36
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1632.346,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.834.28392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.627.99Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5530.977,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.240.41Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.232.347,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.126.93392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.819.56Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1515.687,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1515.687,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.910.476,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.055.83392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.26.81,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.75.347,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.67.74392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9112.7718,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.813.741,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1211.57
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9211.57
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6811.53
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4511.617,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.616.88
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.066.84
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.36.84
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7514.36392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.4810.3519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.29.6Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8312.697,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0812.21Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.915.13Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9214.63Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3215.4Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.212.56Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.558.58Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2519.51Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7922.82Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3220.3Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3220.3Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.414.05Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3812.26Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7816.6Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1216.6Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0815.81Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4414.81Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0613.74Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.713.74Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9224.93Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2124.93Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3525.57Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5129.81Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0829.81Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244431.62Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.238.16Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.238.16Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8738.75Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.634.47Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6532.04Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6828.67Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.230.1Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.629.06Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514066.97Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.161.97Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.459.93Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279109.46Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7893.51Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.496.5Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5394.67Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1597.3Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9297.3Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64102.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13102.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07103.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73103.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81101.24Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3101.24Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9494.93Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6194.93Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5693.9Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4296.77Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7696.77Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.594.8Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.298.64Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58100Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23100Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2898.1Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2128.1Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41123.91Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283106.5Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04107.97Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2485.17Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6884.12Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.287.19Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.888.39Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.473.21Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.572.9Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1473.1Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538950.23Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338651.4Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4850.7Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3250.23Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7947.35Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1571.38Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7971.38Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.669.59Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7866.88Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5271.78Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9471.78Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3470.48Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2569.39Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8767.26Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.645.23Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9543.31Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8443.1Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8844.37Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7844.23Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.252.11Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3345.81Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8846.17Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5846.1Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2541.5Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.143.1Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9241.43Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179838.03Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6538.29Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6540.96Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0441.36Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1445.23Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8540.68Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7446.25Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2746.25Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6846.25Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9146.25Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6549.62Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010046.1Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4449.92Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8849.85Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.849.92Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8849.92Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0450.46Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1750Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1182.51
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1182.51
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6259.93
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8965.18
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199553.79
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9162.6
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6262.6
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8162.6
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4562.6
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.645.23
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5250.15
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7249.46
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.149.46
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4649.46
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8249.46
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2848.17
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6414.72
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9715.63
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.850.62
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5552.74
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.635.78
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3641.84
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3641.84
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.240.14
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8550.54
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0244.87
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1151.79
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1151.79
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.858.8
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9847.06
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9847.06
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.645.74
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.744.87
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3243.52
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.429.81
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3528.89
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4834.1
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6527.43
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0328.78
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0823.45
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460620.54
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1222.98
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125239.14
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1551.71
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20246.1
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0446.69
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7746.76
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4646.76
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0546.76
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2862.42
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522555.84
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.251.63
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6469.69
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0855.1
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.842.68
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1544.44
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2229.41
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1226.99
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1927.38
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4814.41
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8928.95
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9326.49
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4132.82
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8426.66
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4425.89
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9244.94
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8447.28
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2848.4
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.448.32
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5949.31
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3755.76
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9246.76
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9950.31
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1637.96
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018853.71
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9252.51
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2966.4
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8979.04
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8779.04
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.179.04
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0979.04
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7776.13
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6676.13
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.976.13
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6276.13
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9588.52
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6188.52
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0288.52
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.688.52
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8488.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9588.52
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4475.81
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.579.15
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2469.2
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4370.28
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1559.85
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8759.85
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.359.85
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2859.85
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2659.85
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.259.24
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1561.53
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8861.53
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.461.44
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0961.53
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4161.53
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1660.73
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2648.85
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1457.61
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.257.61
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7357.61
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0457.61
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0457.61
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5760.11
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5660.11
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0460.11
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6760.11
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5560.11
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4461.26
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8154.03
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8535.4
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4535.4
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1735.4
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0735.4
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.733
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3841.84
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8841.84
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1341.84
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2641.84
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72107.97Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21107.97Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17107.97Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79143.5Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21143.5Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK